TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
MRVI

Maravai Lifesciences Holdings Inc

Healthcare · Biotechnology

7.70$ +3.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MRVI
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
10.0% 10.5% 26.1% 38.6% 37.2% 47.1% 42.6% 38.4%
4.1% 4.3% 18.6% 28.7% 27.7% 38.7% 32.0% 28.1%
4.1% 4.3% 18.6% 28.7% 27.7% 38.7% 32.0% 28.1%
3.0% 3.1% 4.0% 6.1% 6.4% 3.7% 3.8% 3.3%
2.7% 2.5% 2.6% 2.7% 1.9% 3.5% 5.0% 5.3%
7.9% 16.3% 8.0% 2.4% 5.1% – – –
41.6% 38.8% 17.6% 8.0% 12.4% 21.9% 15.9% 16.8%
40.4% 34.2% 14.0% 6.1% 9.5% 14.9% 19.3% 19.7%
72.6% 75.0% 87.8% 71.6% 60.3% 46.9% 42.8% 51.6%
6.7% 5.1% 10.3% 4.9% 4.8% 5.9% 5.7% 5.8%
0.5% 0.4% 0.5% 0.5% 0.5% 0.9% 1.4% 0.7%
0.7% 1.3% 0.2% 0.4% 0.3% 0.7% 1.2% 0.4%
62.2% 57.9% 41.6% 27.3% 22.9% 34.9% 28.8% 37.2%
26.8% 24.5% 7.0% 16.4% 23.9% 28.0% 32.3% 27.6%
-7.1% -7.3% 0.1% 9.6% 17.7% 19.2% 14.0% 1.3%
16.5% 16.7% 7.6% 6.4% 5.8% 8.9% 13.7% 18.8%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?